Abnormal OGTT results in cancer patients can provide insights into the disease's prognosis. Higher glucose levels often correlate with a more aggressive tumor phenotype and poorer outcomes. Therefore, monitoring glucose metabolism through OGTT can help in stratifying patients based on their risk and tailoring treatment strategies accordingly.
